| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.78▲ | 5.78▲ | 5.78▲ | 5.80▼ | 6.18▼ |
| MA10 | 5.75▲ | 5.76▲ | 5.76▲ | 5.95▼ | 6.36▼ |
| MA20 | 5.78▲ | 5.79▼ | 5.79▼ | 6.21▼ | 5.81▼ |
| MA50 | 5.81▼ | 5.98▼ | 6.06▼ | 6.26▼ | 7.38▼ |
| MA100 | 6.07▼ | 6.28▼ | 6.41▼ | 5.81▼ | 7.13▼ |
| MA200 | 6.40▼ | 6.57▼ | 6.30▼ | 7.09▼ | 8.72▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.017▲ | 0.021▲ | -0.072▼ | 0.122▲ |
| RSI | 49.714▼ | 46.624▼ | 45.120▼ | 38.417▼ | 44.072▼ |
| STOCH | 56.967 | 56.536 | 56.536 | 14.651▼ | 56.613 |
| WILL %R | -33.333 | -33.333 | -33.333 | -83.658▼ | -59.689 |
| CCI | 20.986 | 21.903 | 21.903 | -83.851 | -16.700 |
|
Thursday, October 08, 2026 05:30 AM
Valneva (NASDAQ:VALN) shares declined on Monday after the UK Medicines and Healthcare products Regulatory Agency (MHRA) revoked the marketing authorisation for the company’s Ixchiq chikungunya vaccine ...
|
|
Wednesday, October 07, 2026 01:39 PM
Valneva SE ADRs (NASDAQ:VALN) fell 6.5% in after-hours trading Wednesday after the UK revoked the marketing authorization for its IXCHIQ chikungunya vaccine following a benefit-risk review.
|
|
Wednesday, October 07, 2026 09:00 AM
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that, following a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/10/26 | 5.81 | 5.81 | 5.73 | 5.78 | 5,605 |
| 08/10/26 | 5.612 | 5.74 | 5.612 | 5.69 | 11,261 |
| 07/10/26 | 5.8676 | 5.99 | 5.8676 | 5.87 | 11,164 |
| 06/10/26 | 6.04 | 6.04 | 5.78 | 5.86 | 19,055 |
| 05/10/26 | 5.89 | 5.985 | 5.70 | 5.815 | 69,379 |
| 02/10/26 | 5.84 | 5.8931 | 5.73 | 5.74 | 39,844 |
| 01/10/26 | 6.05 | 6.075 | 5.90 | 5.90 | 34,510 |
| 30/09/26 | 6.19 | 6.27 | 6.16 | 6.185 | 5,837 |
| 29/09/26 | 6.36 | 6.36 | 6.125 | 6.14 | 9,539 |
| 28/09/26 | 6.25 | 6.49 | 6.225 | 6.47 | 21,569 |
|
|
||||
|
|
||||
|
|